Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing, and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency, and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: Reporting to the Executive Director, US Lung Analytics & Insights, the Director, US Lung Market Research will serve as the US Market Research lead for Revolution Medicines’ Lung cancer portfolio. This role will partner closely with US Commercial, US Market Access, Global Insights, Medical Affairs, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance. The role requires a strong understanding of the NSCLC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets. This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director